The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death

Anti-Cancer Drugs

Volumn 18, Issue 6, 2007, Pages 659-667

  Nigro, Cristiana Lo ^a   Arnolfo, Elena ^a   Taricco, Enrico ^a   Fruttero, Adriana ^a   Russi, Elvio Grazioso ^a   Lucio, Francesco ^a   Ribero, Silvana ^a   Comino, Alberto ^a   Merlano, Marco ^a   Ungari, Silvana ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Apoptosis; Cisplatin; Clonogenic death effect; Radiation

Indexed keywords

CISPLATIN; MESSENGER RNA; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL DEATH; CELL KILLING; CELL KINETICS; CELL SURVIVAL; CLONOGENESIS; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTING; MOLECULAR DYNAMICS; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TERATOCARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; FLOW CYTOMETRY; GENE EXPRESSION; MICE; NECROSIS; RADIATION, IONIZING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548357031     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328087388f     Document Type: Article

References (52)

1. Viktorsson K, Lewensohn R, Zhivotovsky B. Apoptotic pathways and therapy resistance in human malignancies. Adv Cancer Res 2005; 94:143-196.
2. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4:139-163.
3. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005; 73:1907-1916.
4. Ryu MR, Paik SY, Chung SM. Combined effect of heptaplatin and ionizing radiation on human squamous carcinoma cell lines. Mol Cells 2005; 19:143-148.
5. Merlano M, Benasso M, Corvò R, Rosso R, Vitale V, Blengio F, et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996; 88:583-589.
6. Merlano M, Vitale V, Rosso R, Benasso M, Corvo R, Cavallari M, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327:1115-1121.
7. Wendt TG, Grabenbauer GG, Rodel CM, Rodel CM, Thiel HJ, Aydin H, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998; 16:1318-1324.
8. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338:1798-1804.
9. Loehrer PJ, Einhorn LH. Drugs five years later. Cisplatin. Ann Intern Med 1984; 100:704-713.
10. Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 1990; 82:749-755.
11. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1:3-11.
12. Lowndes NF, Murguia JR. Sensing and responding to DNA damage. Curr Opin Genet Dev 2000; 10:17-25.
13. Wahl GM, Carr AM. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol 2001; 3:E277-E286.
14. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004; 4:592-603.
15. Bergs JW, Franken NA, Ten Cate R, van Bree C, Haveman J. Effects of cisplatin and gamma-irradiation on cell survival, the induction of chromosomal aberrations and apoptosis in SW-1573 cells. Mutat Res 2006; 594:148-154.
16. Benchimol S. p53-dependent pathways of apoptosis. Cell Death Differ 2001; 8:1049-1051.
17. Attardi LD, Lowe SW, Brugarolas J, Jacks T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J 1996; 15:3693-3701.
18. Lin Y, Ma W, Benchimol S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet 2000; 26:122-127.
19. Burns TF, Fei P, Scata KA, Dicker DT, El-Deiry WS. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol Cell Biol 2003; 23:5556-5571.
20. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59:928-942.
21. Loprevite M, Favoni RE, de Cupis A, Pirani P, Pietra G, Bruno S, et al. Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines. Lung Cancer 2001; 33:27-39.
22. Raaphorst GP, Leblanc M, Li LF. A comparison of response to cisplatin, radiation and combined treatment for cells deficient in recombination repair pathways. Anticancer Res 2005; 25:53-58.
23. Blelloch RH, Hochedlinger K, Yamada Y, Brennan C, Kim M, Mintz B, et al. Nuclear cloning of embryonal carcinoma cells. Proc Natl Acad Sci U S A 2004; 28:3985-3990.
24. Pera MF, Friedlos F, Mills J, Roberts JJ. Inherent sensitivity of cultured human embryonal carcinoma cells to adducts of cis- diamminedichloroplatinum (II) on DNA. Cancer Res 1987; 47:6810-6813.
25. Schechter B, Wilchek M, Arnon R. Increased therapeutic efficacy of cisplatinum complexes of poly-glutamic acid against a murine carcinoma. Int J Cancer 1987; 39:409-413.
26. Doi T, Sumi T, Nishina Y, Kosaka M, Iwai SA, Sakuda M, et al. Induction of teratocarcinoma F9 cell differentiation with cis-diammine dichloroplatinum (II) (CDDP). Cancer Lett 1995; 88:81-86.
27. Malashicheva AB, Kislyakova TV, Aksenov ND, Osipov KA, Pospelov VA. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation. Oncogene 2000; 19:3858-3865.
28. Zeng X, Keller D, Wu L, Lu H. UV but not gamma irradiation accelerates p53-induced apoptosis of teratocarcinoma cells by repressing MDM2 transcription. Cancer Res 2000; 60:6184-6188.
29. Langley RE, Bump EA, Quartuccio SG, Medeiros D, Braunhut SJ. Radiation-induced apoptosis in microvascular endothelial cells. Br J Cancer 1997; 75:666-672.
30. Tisman G, Herbert V, Edlis H. Determination of therapeutic index of drugs by in vitro sensitivity tests using human host and tumor cell suspensions. Cancer Chemother Rep 1973; 57:11-19.
31. Corvo R, Paoli G, Giaretti W, Sanguineti G, Geido E, Benasso M, et al. Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2000; 47:57-63.
32. Weisenthal LM, Mersden JA, Dill PL, Macalusu CK. A novel dye exclusion method for testing in vitro chemiosensitivity of human tumors. Cancer Res 1983; 43:749-757.
33. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989.
34. Harwood SM, Yaqoob MM, Allen DA. Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis. Ann Clin Biochem 2005; 42:415-431.
35. Vermeulen K, Van Bockstaele DR, Berneman ZN. Apoptosis: mechanisms and relevance in cancer. Ann Hematol 2005; 84:627-639.
36. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. Cancer J Clin 2005; 55:178-194.
37. Zong WX, Thompson CB. Necrotic death as a cell fate. Genes Dev 2006; 20:1-15.
38. Falkvoll KH. The occurrence of apoptosis, abnormal mitoses, cells dying in mitosis and micronuclei in a human melanoma xenograft exposed to single dose irradiation. Strahlenther Onkol 1990; 166:487-492.
39. Radford IR, Murphy TK. Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage. Int J Radiat Biol 1994; 65:229-239.
40. Guo M, Chen C, Vidair C, Marino S, Dewey WC, Ling CC. Characterization of radiation-induced apoptosis in rodent cell lines. Radiat Res 1997; 147:295-303.
41. Tannock IF, Lee C. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br J Cancer 2001; 84:100-105.
42. Kumala S, Niemiec P, Widel M, Hancock R, Rzeszowska-Wolny J. Apoptosis and clonogenic survival in three tumour cell lines exposed to gamma rays or chemical genotoxic agents. Cell Mol Biol Lett 2003; 8:655-665.
43. Russell J, Ling CC. Studies with cytotoxic agents suggest that apoptosis is not a major determinant of clonogenic death in neuroblastoma cells. Eur J Cancer 2003; 39:2234-2238.
44. Bergman PJ, Harris D. Radioresistance, chemoresistance, and apoptosis resistance. The past, present, and future. Vet Clin North Am Small Anim Pract 1997; 27:47-57.
45. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995; 7:541-546.
46. Fei P, Bernhard EJ, El-Deiry WS. Tissue-specific induction of p53 targets in vivo. Cancer Res 2002; 62:7316-7327.
47. Zamble DB, Jacks T, Lippard SJ. p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci U S A 1998; 95:6163-6168.
48. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG Jr, Levrero M, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999; 399:806-809.
49. Yoneda K, Yamamoto T, Osaki T. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation. Oral Oncol 1998; 34:529-537.
50. Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996; 10:2438-2451.
51. Lee BJ, Chon KM, Kim YS, An WG, Roh HJ, Goh EK, Wang SG. Effects of cisplatin, 5-fluorouracil, and radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line. Chemotherapy 2005; 51:103-110.
52. Wang X, Wong SC, Pan J, Tsao SW, Fung KH, Kwong DL, et al. Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Cancer Res 1998; 58:5019-5022.